Scinai Immunotherapeutics (SCNI) Interest Coverage Ratio (2015 - 2022)

Scinai Immunotherapeutics has disclosed Interest Coverage Ratio across 8 years of filings, most recently posting 0.88 for Q4 2022.

• In Q4 2022, Interest Coverage Ratio fell 78.22% year-over-year to 0.88; the TTM figure through Dec 2022 stood at 0.1 (down 98.77% YoY), while the FY2023 annual figure was 10.31, down 101.96% from the prior year.
• Interest Coverage Ratio came in at 0.88 for Q4 2022 at Scinai Immunotherapeutics, up from 0.35 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 135.47 in Q1 2020 to a low of 193.07 in Q3 2020.
• Average Interest Coverage Ratio over 5 years is 2.38, with a median of 2.88 recorded in 2021.
• The largest YoY upside for Interest Coverage Ratio was 3724.82% in 2020 against a maximum downside of 713.18% in 2020.
• Over 5 years, Interest Coverage Ratio stood at 3.65 in 2018, then surged by 762.11% to 31.49 in 2019, then slumped by 99.5% to 0.16 in 2020, then jumped by 2442.4% to 4.02 in 2021, then sank by 78.22% to 0.88 in 2022.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.88 in Q4 2022, 0.35 in Q3 2022, and 0.9 in Q2 2022.